Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2024-08-26 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
变更募集资金用途的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the change in the use of raised funds by Shanghai Chunguang Medical Technology Co., Ltd. It includes specifics about the original fundraising, the amounts raised, the usage progress, and the reasons for changing the use of the funds. It also discusses the company's strategic plans, project feasibility, and approvals from the board and supervisory committee. The document is not a full financial report but an update on capital usage and fundraising allocation. This fits the definition of a Capital/Financing Update (CAP) filing, as it provides updates on company fundraising and capital structure changes. The document length (6144 characters) and content confirm it is not a mere announcement of a report but a substantive update on capital usage.
2024-08-26 Chinese
第五届董事会第十二次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 12th meeting of the 5th Board of Directors of Shanghai Chenguang Medical Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to other related announcements and reports disclosed on the Beijing Stock Exchange information platform. The document does not contain the actual financial report or detailed financial data but rather the board's decisions and approvals related to various company matters, including approval of the 2024 semi-annual report and other financial and operational proposals. This type of document is a Board/Management Information announcement, as it reports on board meeting resolutions and management decisions rather than the full report itself or a simple announcement of report publication.
2024-08-26 Chinese
关于召开2024年第二次临时股东大会通知公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2024 second extraordinary general meeting of shareholders (临时股东大会) for Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, voting methods, agenda items to be discussed, registration procedures, and other logistical information. It does not contain financial statements, audit results, or detailed financial data. The document is primarily an announcement about the meeting itself, not the meeting minutes or voting results. It also references other announcements for detailed content of proposals. The document length is 2857 characters, which is relatively short and consistent with a meeting notice. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-08-26 Chinese
第五届监事会第七次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, attendance, and voting results on several agenda items, including approval of the 2024 semi-annual report and related reports. The document references the actual semi-annual report and other reports being disclosed on the Beijing Stock Exchange information platform, indicating that this document itself is not the report but an announcement of the meeting resolutions. The document length is short (1356 characters), and it does not contain substantive financial data or the full report content. Therefore, it fits the category of a Regulatory Filing (RNS) as a formal announcement of meeting resolutions and approvals rather than the report itself or a detailed financial report.
2024-08-26 Chinese
关于子公司完成工商登记及公司章程备案并取得营业执照的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Shanghai Chenguang Medical Technology Co., Ltd. regarding the completion of business registration and company charter filing for its subsidiary, Shanghai Chengzhan Medical Technology Co., Ltd., and the obtaining of a business license. It includes details about the subsidiary's registration, legal representative, registered capital, business scope, and licensing. The document is short (1231 characters) and serves as an official notice of a corporate event rather than a financial report or detailed management information. It does not contain financial statements, audit information, or detailed management discussion. It is not a report publication announcement since it does not mention the release or availability of a report. It is not related to board changes, voting results, or capital changes. Therefore, the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous official announcements that do not fit other specific categories.
2024-06-03 Chinese
持股5%以上股东提前终止减持计划暨减持股份结果公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the termination of a planned shareholding reduction by a shareholder holding more than 5% of the company's shares. It details the shareholder's identity, shareholding percentages, and the fact that the planned reduction was not executed and was terminated early. This fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes or planned changes in significant share ownership levels. The document is short and focused solely on this shareholder activity, with no financial statements or other report content. Therefore, the correct classification is MRQ.
2024-05-29 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.